Search for Clinical Trial Results

Sponsored By

Minimal Change Disease - 19 Studies Found

Status Study
Recruiting Study Name: Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
Condition: Minimal Change Disease
Date: 2009-09-21
Interventions:
  • Drug: tacrolimus tacrolimus0.0
Completed Study Name: Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome
Condition: Minimal Change Disease
Date: 2010-03-10
Interventions: Drug: Tacrolimus tacrolimus 0.05mg/kg bid for 12 weeks corticosteroid 0.3 - 0.5mg/kg qd
Active, not recruiting Study Name: A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome
Condition:
  • MCNS
  • Minimal Change Nephrotic Syndrome (MCNS)

Date: 2012-12-06
Interventions:
  • Drug: Tacrolimus Oral

Completed Study Name: The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
Condition: IgA Nephropathy
Date: 2011-10-07
Interventions: Drug: Prednisone or Prednisolone daily single dose of 1mg/kg (maximum 80mg) or alternate day single dose
Completed Study Name: Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
Condition: Nephrotic Syndrome
Date: 2009-09-21
Interventions: Drug: Rituximab Rituximab (375 mg/m2) will be given as a single intravenous infusion after reconstitutio
Recruiting Study Name: Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study
Condition: Nephrosis, Lipoid
Date: 2010-08-13
Interventions:
  • Drug: Myfortic plus low-dose steroid

Recruiting Study Name: Nephrotic Syndrome Study Network
Condition:
  • Minimal Change Disease (MCD)
  • Membranous Nephropathy
  • Date: 2010-07-29
    Interventions: Procedure: Kidney Biopsy Patients scheduled to undergo a clinically indicated kidney biopsy will be requ
Not yet recruiting Study Name: Valproic Acid for Idiopathic Nephrotic Syndrome
Condition:
  • Idiopathic Nephrotic Syndrome
  • Focal Segmental Glomerulosclerosis
  • Collapsing Glomerulopathy
  • Glomerulosclerosis, Focal Segmental

Date: 2004-12-01
Interventions:
  • Procedure: Kidney needle biopsy
  • Procedure:
Recruiting Study Name: Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
Condition: Nephrotic Syndrome
Date: 2015-10-29
Interventions:
  • Drug: Abatacept
  • Other: Normal Saline
Next >>>